HOME › DRUGS › DEXPANTHENOL
ACTIVE SUBSTANCE / INN

DEXPANTHENOL

Brand name(s): BEROCCA PN, M.V.I. PEDIATRIC, M.V.I.-12 ADULT, M.V.I.-12 LYOPHILIZED, M.V.C. 9+3, M.V.I. ADULT (PHARMACY BULK PACKAGE), INFUVITE ADULT, MVC PLUS, INFUVITE PEDIATRIC, INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA021163
NDA006071
ACTIVE SUBSTANCE
Dexpanthenol
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, ROCHE, HOSPIRA
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
INFUVITE ADULTNDA021163SANDOZ CANADA INCPrescription
M.V.I.-12 LYOPHILIZEDNDA018933TELIGENTDiscontinued
MVC PLUSNDA018439WATSON LABSDiscontinued
M.V.C. 9+3NDA018440ABRAXIS PHARMDiscontinued
M.V.I.-12 ADULTNDA008809HOSPIRADiscontinued
M.V.I. ADULT (PHARMACY BULK PACKAGE)NDA021643HOSPIRADiscontinued
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)NDA021265SANDOZ CANADA INCPrescription
INFUVITE PEDIATRICNDA021265SANDOZ CANADA INCPrescription
BEROCCA PNNDA006071ROCHEDiscontinued
M.V.I. PEDIATRICNDA018920HOSPIRADiscontinued

FULL INTELLIGENCE ON DEXPANTHENOL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →